- Home
- SCZM vs LXRX Comparison
SCZM vs LXRX Comparison
Compare SCZM & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCZM | LXRX |
|---|---|---|
| Founded | N/A | 1995 |
| Country | Canada | United States |
| Employees | 455 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 847.1M | 996.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | SCZM | LXRX |
|---|---|---|
| Price | $7.57 | $1.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $17.16 | $4.47 |
| AVG Volume (30 Days) | 358.8K | ★ 1.8M |
| Earning Date | 11-27-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | $44.52 | N/A |
| Revenue Next Year | $13.48 | N/A |
| P/E Ratio | $14.27 | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $5.61 | $1.10 |
| 52 Week High | $17.65 | $2.68 |
Technical Indicators
Market Signals| Indicator | SCZM | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 34.04 |
| Support Level | $5.95 | $1.39 |
| Resistance Level | $7.01 | $1.79 |
| Average True Range (ATR) | 0.37 | 0.09 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 8.06 | 30.16 |
Price Performance
Historical ComparisonAbout SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.